Plasma expanders
Plasma expanders for therapeutic or prophylactic use
HSN 3004 90 92 (Plasma expanders) is subject to Central Drugs Standard Control Organisation (CDSCO) import licensing and registration under the Drugs and Cosmetics Act, 1940, with mandatory document verification at the bill-of-entry stage. The Directorate General of Foreign Trade (DGFT) administers an ITC (HS) policy overlay that includes a categorical prohibition on oxytocin import under S.O. 2357(E) and DGFT Notification 09/2015-2020 dated 23-05-2022. Ministry of Environment, Forest and Climate Change conditions apply to used or refurbished medical equipment within this tariff line.
- Import licence for drugs from CDSCO
- Registration certificate from CDSCO
- Certificate of analysis from exporter
Procedural directions for customs clearance are issued by: Directorate General of Foreign Trade.
- 1Obtain a current Import Licence for drugs (document code 9111dc) and a Registration Certificate for drugs (document code 101dc1) from CDSCO before shipment. Both documents must be uploaded in e-Sanchit, along with a Certificate of Analysis (document code 0010dc), a Batch Release Certificate (document code 0030dc), and the Label of consignment (document code 0110dc), before customs out-of-charge is granted.Drugs and Cosmetics Act, 1940 · CDSCO drug import regime · document codes 9111dc, 101dc1, 0010dc, 0030dc, 0110dc
- 2Verify that the consignment does not contain oxytocin. Import of oxytocin is prohibited; the sole exemption covers oxytocin reference standards imported exclusively for test and analysis purposes, subject to a test licence issued by DGCI/CDSCO. The prohibition is operative under S.O. 2357(E) and DGFT Notification 09/2015-2020 dated 23-05-2022.S.O. 2357(E) dated 23-05-2022 · DGFT Notification 09/2015-2020 dated 23-05-2022
- 3If the goods comprise used or refurbished medical equipment, comply with the conditions stipulated in the Office Memorandum issued by the Ministry of Environment, Forest and Climate Change dated 15-12-2023, under which import of high-end and high-value used or refurbished medical equipment other than critical-care medical equipment is Restricted.O.M. issued by Ministry of Environment, Forest and Climate Change dated 15-12-2023
The most common error on this tariff line is conflating the oxytocin prohibition with a general exclusion rather than a product-specific categorical ban: importers occasionally ship formulations containing oxytocin as a secondary constituent believing the prohibition applies only to standalone oxytocin preparations. Any oxytocin content in the consignment — other than reference standards accompanied by a DGCI/CDSCO test licence — triggers confiscation and prosecution under both the Drugs and Cosmetics Act, 1940 and the DGFT policy condition in S.O. 2357(E).